Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Pathogens (Basel, Switzerland)|September 23, 2022
Genetic Variants of Glucose-6-Phosphate Dehydrogenase and Their Associated Enzyme Activity: A Systematic Review and Meta-AnalysisDaniel A Pfeffer, Ari Winasti Satyagraha, Arkasha Sadhewa, et al.
Plos Neglected Tropical Diseases|April 30, 2025
Decentralization of snakebite antivenom treatment to indigenous community health centers in the Brazilian Amazon: From demand to the first treatment (the SAVING Program)Altair Seabra de Farias, Thiago Serrão-Pinto, Deugles Cardoso, et al.
BMC Infectious Diseases|April 7, 2026
Optimising COVID-19 episode identification using serology and PCR/rapid antigen testing: insights from the BRACE trialEllie McDonald, Laure F Pittet, Marc Bonten, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2025
Safety and efficacy of three alternative regimens against relapsing Plasmodium vivax malaria in glucose 6-phosphate dehydrogenase deficient patients in the Brazilian Amazon (ALTPRIM)Laila Barbosa, José Brito-Sousa, Cristiana Nascimento, et al.
Nature Medicine|May 15, 2020
Development and validation of serological markers for detecting recent Plasmodium vivax infectionRhea J Longley, Michael T White, Eizo Takashima, et al.
Toxins|June 23, 2022
Validation of a Culturally Relevant Snakebite Envenomation Clinical Practice Guideline in BrazilGisele Dos Santos Rocha, Altair Seabra Farias, João Arthur Alcântara, et al.
Malaria Journal|January 30, 2022
Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealthDiego Macías Saint-Gerons, Sheila Rodovalho, Ádila Liliane Barros Dias, et al.
Plos One|June 22, 2026
Effectiveness of CoronaVac in a pioneer risk-based allocation clinical trial during the COVID-19 pandemicAlex Martins, Mario Felipe Bosco Santos, Joabi Nascimento, et al.
Pageof 9